Piper Sandler Reiterates Neutral Rating on Thermo Fisher Scientific Inc. (TMO)

Market Context

Thermo Fisher Scientific Inc. operates in the Healthcare sector. The stock currently trades at $559.53 with a market capitalization of $219.4B. The stock has declined 3.3% over the past 52 weeks.

Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Thermo Fisher Scientific Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Thermo Fisher Scientific Inc.

Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 27, 2026	Morgan Stanley	Overweight	N/A
Jul 27, 2026	Piper Sandler	Neutral	N/A
Jul 24, 2026	Barclays	Overweight	N/A
Jul 24, 2026	RBC Capital	Sector Perform	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View TMO Stock Page